Literature DB >> 2923920

Activation of glutamate dehydrogenase by L-leucine.

I Couée1, K F Tipton.   

Abstract

The activation of glutamate dehydrogenase (L-glutamate: NAD(P)+ oxidoreductase (deaminating), EC 1.4.1.3) by L-leucine has been studied. Apparently homogeneous preparations from ox liver and brain were found to respond similarly. Commercially obtained preparations of the enzyme, which had suffered limited proteolysis during the purification procedure, were shown to behave similarly to preparations which had not suffered such proteolysis when the effects of L-leucine on the oxidative deamination reaction were studied using either NAD+ or NADP+ as the coenzyme. There was also no significant difference in the responses when the reductive reaction was determined with NADPH or with 40 microM NADH. At higher concentrations of NADH (160 microM) the unproteolysed preparations were activated by L-leucine to a considerably greater extent than those which had suffered limited proteolysis. These results accord with the greater sensitivity of the former preparations to inhibition by high concentrations of NADH and the relief of such inhibition by L-leucine. This amino acid was also found to relieve the inhibition of the enzyme by GTP, resulting in an apparent increase in the activation observed in the presence of this nucleotide. In contrast, under the conditions used in this work, the apparent degree of activation by L-leucine was found to be decreased in the presence of the activators ATP or ADP. The presence of high concentrations of NADH (200 microM) potentiated the high substrate inhibition by 2-oxoglutarate, and L-leucine significantly reduced this effect. The effects of L-leucine on the activity of glutamate dehydrogenase thus appear to be composed of a direct effect on the activity of the enzyme together with a relief of high substrate inhibition. The effects of GTP and 2-oxoglutarate in potentiating inhibition by NADH can account for their effects in enhancing the apparent activation by L-leucine. The marked differences in the responses of proteolysed and unproteolysed preparations of the enzyme result from the effects of proteolysis in decreasing the sensitivity to high concentrations of NADH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923920     DOI: 10.1016/0167-4838(89)90239-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Effect of alpha-ketoisocaproate and leucine on the in vivo oxidation of glutamate and glutamine in the rat brain.

Authors:  H R Zielke; Y Huang; P J Baab; R M Collins; C L Zielke; J T Tildon
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

2.  The sulphydryl groups of ox brain and liver glutamate dehydrogenase preparations and the effects of oxidation on their inhibitor sensitivities.

Authors:  I Couée; K F Tipton
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

Review 3.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

4.  The effects of phospholipids on the activation of glutamate dehydrogenase by L-leucine.

Authors:  I Couée; K F Tipton
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

Review 5.  Glutamate Dehydrogenase, a Complex Enzyme at a Crucial Metabolic Branch Point.

Authors:  Hong Q Smith; Changhong Li; Charles A Stanley; Thomas James Smith
Journal:  Neurochem Res       Date:  2017-10-27       Impact factor: 3.996

6.  Structural Basis for the Binding of Allosteric Activators Leucine and ADP to Mammalian Glutamate Dehydrogenase.

Authors:  Vasily A Aleshin; Victoria I Bunik; Eduardo M Bruch; Marco Bellinzoni
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

7.  Glutaminolysis is involved in the activation of mTORC1 in in vitro-produced porcine embryos.

Authors:  Paula R Chen; Caroline G Lucas; Lee D Spate; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2021-06-01       Impact factor: 2.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.